DIA Canada

This is a presentation on innovative global regulatory strategies using a case study that will provide practical regulatory recommendations on how to speed up drug development and reduce drug development costs while meeting high quality drug approval standards set by Health Authorities. A blueprint for product development with appropriate regulatory interactions will be shared followed by a discussion of regulatory incentives and pathways that may be leveraged for product development.